Reversal of Anticoagulation : Protamine

Holst, Jan (author): Lund University,Lunds universitet,Vaskulära sjukdomar - kliniska studier,Forskargrupper vid Lunds universitet,Vascular Diseases - Clinical Research,Lund University Research Groups,Skåne University Hospital

Waksman, Ron (editor)

Ajani, Andrew E. (editor)

(creator_code:org_t)

Oxford, UK : Wiley-Blackwell, 2009
2009
English.
In: Pharmacology in the Catheterization Laboratory. - Oxford, UK : Wiley-Blackwell. - 9781405157049 - 9781444306347 ; , s. 287-293

Related links:: http://dx.doi.org/10...; show more...; https://lup.lub.lu.s...; https://doi.org/10.1...; show less...

Subject headings

MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Haemodynamic adverse response to protamine reversal of anticoagulation
Low-molecular-weight heparins (LMWH) as anticoagulant agents
Mechanism of action-reversal of heparinization
Monitoring neutralizing effect of protamine
New pharmacological agents-direct thrombin inhibitors and factor Xa inhibitors
Nonimmunological reactions-cell-membrane interactions and cascade systems interactions
Reversal of anticoagulation-protamine
Tissue factor pathway inhibitor (TFPI)
Type I and III immunological reactions and Coombs and Gell's classification
Unfractionated heparin (UH)-substance of choice minimizing risk of thrombotic complications

By the author/editor: Lindblad, Bengt; Holst, Jan; Waksman, Ron; Ajani, Andrew E.

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cardiac and Card ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.